CVS Health (CVS) is moving back into the spotlight, and this time it is not because of a headline-grabbing event. If you follow blue-chip healthcare stocks, even subtle shifts like this can raise ...

Shares of diversified healthcare company CVS Health (NYSE:CVS) fell 4.8% in the afternoon session after two Republican congressmen launched an investigation into the company over concerns it may have ...

CVS Health (CVS) announced that updated 2025-2026 flu vaccines are available at CVS Pharmacy and MinuteClinic locations nationwide. According to the Centers for Disease Control and Prevention, annual ...

CVS Pharmacy is expanding access to COVID-19 vaccines in Kentucky, among other states. As of Sept. 9, officials with the major pharmacy chain confirmed it can now offer COVID-19 vaccines in Kentucky ...

A national pharmacy chain will not offer COVID-19 vaccine shots in more than a dozen states. CVS says it won't provide the shots in 16 states, including Pennsylvania, regardless of if a person meets ...

Pennsylvania officials this week authorized eligible people to get a covid-19 vaccine without a prescription. The state said the change took effect immediately. But, as of Friday afternoon, patients ...

The nation’s largest retail pharmacy chain now plans to offer the updated COVID vaccine in Nevada, the Nevada Current confirmed Friday. CVS confirmed the Nevada Board of Pharmacy issued new guidance ...

WILMINGTON, N.C. (WECT) - Changes by the Food and Drug Administration (FDA) resulted in CVS and Walgreens Pharmacies in North Carolina now requiring a doctor’s prescription for anyone who does not ...

A class-action lawsuit accuses CVS Caremark of denying medically necessary treatments by stopping coverage of Zepbound, Eli Lilly’s blockbuster weight-loss drug. CVS Caremark stopped covering Zepbound ...

Daniel Orton is an editor on the live news team at Newsweek, based in London, U.K. He was previously a video news editor at the company between 2017 and 2019, before spending several years as a senior ...

A class-action lawsuit has been filed against CVS Caremark over its decision to stop covering Zepbound, Eli Lilly’s blockbuster GLP-1 drug to treat obesity. When the major pharmacy benefit manager ...